Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Starlight Cardiovascular
AddedFeb 15, 2024
UpdatedJun 18, 2026
Starlight Cardiovascular

Starlight Cardiovascular

Starlight Cardiovascular: Innovating pediatric heart disease treatment with specialized devices.

HQ
San Diego, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Starlight Cardiovascular, founded with the mission to innovate pediatric heart disease treatment, focuses on developing specialized devices for babies born with congenital heart disease. Recognizing that existing tools are designed for adult conditions and anatomy, Starlight aims to improve morbidity and mortality rates among pediatric patients through tailored medical devices.

The company has garnered attention for its impactful approach and has attracted notable partners and investors committed to advancing pediatric healthcare. Starlight Cardiovascular's achievements include the development of a portfolio of devices specifically designed for young patients, significantly enhancing treatment outcomes and quality of life for children with congenital heart conditions.

Starlight Cardiovascular - Similar Companies

Phoenix Cardiac logo

Phoenix Cardiac

Renata Medical logo

Renata Medical

renatamedical.com

PolyVascular logo

PolyVascular

polyvascular.com

CardioOptics logo

CardioOptics

Cardiac Dimensions logo

Cardiac Dimensions

Native Cardio logo

Native Cardio

nativecardio.com

InvisionHeart logo

InvisionHeart

invisionheart.com

Scion Cardio-Vascular logo

Scion Cardio-Vascular

CardieX logo

CardieX

cardiex.com

Cardiovate logo

Cardiovate

Cross Vascular logo

Cross Vascular

Reprieve Cardiovascular logo

Reprieve Cardiovascular

reprievecardio.com

Peca Labs logo

Peca Labs

pecalabs.com

Cardio Flow logo

Cardio Flow

cardioflow.net

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

Starlight Cardiovascular - Quick Facts

Who are Starlight Cardiovascular's competitors?

Companies similar to Starlight Cardiovascular include Phoenix Cardiac, Renata Medical, PolyVascular and CardioOptics.

When was Starlight Cardiovascular founded?

Starlight Cardiovascular was founded in 2020.

Where is Starlight Cardiovascular's headquarters located?

Starlight Cardiovascular's headquarters is located in San Diego, CA, US.

When was Starlight Cardiovascular's last funding round?

Starlight Cardiovascular's most recent funding round was for $2.2M (USD) in March 2023.

How much has Starlight Cardiovascular raised to-date?

As of Mar 22, 2023, Starlight Cardiovascular has raised a total of $11.6M (USD).

How many employees does Starlight Cardiovascular have?

Starlight Cardiovascular has 8 employees as of Feb 4, 2024.

Starlight Cardiovascular - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified